Hippocampus, synaptic plasticity and anxiety vulnerability
海马、突触可塑性和焦虑脆弱性
基本信息
- 批准号:9788182
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2019-09-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAnxietyAnxiety DisordersAttenuatedAvoidance LearningBasic ScienceBehaviorBehavioralBehavioral inhibitionBrainBrain-Derived Neurotrophic FactorCost SavingsCycloserineDevelopmentDiseaseEffectivenessElectric StimulationEnvironmentEtiologyEvoked PotentialsFunctional disorderGeneral PopulationHealthHippocampus (Brain)HumanImpairmentInbred StrainInbred WKY RatsIndividualKnowledgeLateralLeadLearningLong-Term PotentiationMedialMedicalN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNeurotrophic Tyrosine Kinase Receptor Type 2Opiate AddictionOpioidOpioid AntagonistOpioid ReceptorOpioid agonistPatientsPerforant PathwayPharmaceutical PreparationsPost-Traumatic Stress DisordersPsychiatryPsychopathologyRiskRisk FactorsServicesSprague-Dawley RatsStressSynaptic plasticitySystemTemperamentTestingTimeTrainingVeteransWarWorkanxiety-related disordersbrain abnormalitiesbrain dysfunctioncombatdentate gyrusmedical specialistmu opioid receptorsneurotrophic factorpreventpublic health relevancestressortherapy developmenttreatment of anxiety disorders
项目摘要
DESCRIPTION (provided by applicant):
Risk factors for anxiety disorder are important in determining who ultimately develops the disorder. However, our understanding of risk factors is rudimentary. Identification of the mechanisms of risk factors would be a step forward in understanding the etiology of anxiety disorders. Reduced hippocampal volume, dysfunction of the brain-derived neurotrophin factor (BDNF) system and behavioral inhibition temperament are three anxiety risk factors identified in humans. The risk factor of reduced hippocampal volume is associated with impaired hippocampal-dependent learning, suggesting impaired hippocampal synaptic plasticity in individuals at risk. BDNF is important for synaptic plasticity. Thus, we hypothesize that impaired hippocampal synaptic plasticity may underlie the risk factors of both reduced hippocampal volume and BDNF dysfunction. The Wistar Kyoto (WKY) rat is an inbred strain that is stress sensitive, has a reduced hippocampal volume compared to the outbred Sprague Dawley (SD) rat, has an abnormal BDNF system and expresses a behavioral inhibition. In addition, WKY rats acquire active avoidance to a greater and more persistent degree than SD rats. Abnormal avoidance is a core feature of all anxiety disorders, and the development of abnormal avoidance parallels the trajectory of PTSD (cluster C). Thus, the proposed studies will test whether impaired synaptic plasticity in the hippocampus contributes to the development of abnormal avoidance learning in the presence and absence of behavioral inhibition temperament. Four aims are proposed. Aim 1 will determine whether BDNF-induced synaptic plasticity is impaired in the hippocampus of WKY rats and if NMDA and BDNF agonists can attenuate these impairments. Aim 2 will investigate the effects of drugs acting on NMDA and BDNF-TrkB receptors on avoidance learning. Aim 3 will determine if opioid-dependent LTP in the hippocampus is impaired in WKY rats. Opioid-dependent LTP does not require NMDA or TrkB receptors. Aim 4 will investigate whether drugs acting on opioid receptors can affect the development of abnormal avoidance responding. Because opioid-dependent LTP is independent of NMDA and TrkB receptors, the comparison of opioid LTP to NMDA- and BDNF-LTP will determine whether the development of abnormal avoidance requires impairment of a specific type of LTP (i.e., NMDA) or if impairment to any of the various forms of LTP in the hippocampus can lead to the development of abnormal avoidance. The proposed studies will start to elucidate the mechanisms and interactions of three risk factors for anxiety disorders. Understanding the etiology of anxiety disorders and mechanisms of risk factors will help in the development of treatments. This is especially important to the health of veterans because a significant number of veterans are likely to develop anxiety-related disorders as a result of the extreme stress associated with combat service.
描述(由申请人提供):
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Paired-housing selectively facilitates within-session extinction of avoidance behavior, and increases c-Fos expression in the medial prefrontal cortex, in anxiety vulnerable Wistar-Kyoto rats.
在焦虑易感的 Wistar-Kyoto 大鼠中,配对饲养选择性地促进会话内回避行为的消失,并增加内侧前额叶皮质中的 c-Fos 表达。
- DOI:10.1016/j.physbeh.2016.05.044
- 发表时间:2016
- 期刊:
- 影响因子:2.9
- 作者:Smith,IanM;Pang,KevinCH;Servatius,RichardJ;Jiao,Xilu;Beck,KevinD
- 通讯作者:Beck,KevinD
Corrigendum: Use of the Exponential and Exponentiated Demand Equations to Assess the Behavioral Economics of Negative Reinforcement.
勘误表:使用指数和指数需求方程评估负强化的行为经济学。
- DOI:10.3389/fnins.2017.00376
- 发表时间:2017
- 期刊:
- 影响因子:4.3
- 作者:Fragale,JenniferEC;Beck,KevinD;Pang,KevinCH
- 通讯作者:Pang,KevinCH
Neurocognitive and Fine Motor Deficits in Asymptomatic Adolescents during the Subacute Period after Concussion.
脑震荡后亚急性期无症状青少年的神经认知和精细运动缺陷。
- DOI:10.1089/neu.2017.5314
- 发表时间:2018
- 期刊:
- 影响因子:4.2
- 作者:Servatius,RichardJ;Spiegler,KevinM;Handy,JustinD;Pang,KevinCH;Tsao,JackW;Mazzola,CatherineA
- 通讯作者:Mazzola,CatherineA
Danger and safety signals independently influence persistent pathological avoidance in anxiety-vulnerable Wistar Kyoto rats: A role for impaired configural learning in anxiety vulnerability.
危险和安全信号独立影响焦虑易感 Wistar京都大鼠的持续病理性回避:配置学习受损在焦虑脆弱性中的作用。
- DOI:10.1016/j.bbr.2018.07.025
- 发表时间:2019
- 期刊:
- 影响因子:2.7
- 作者:Spiegler,KevinM;Smith,IanM;Pang,KevinCH
- 通讯作者:Pang,KevinCH
Dataset of active avoidance in Wistar-Kyoto and Sprague Dawley rats: Experimental data and reinforcement learning model code and output.
Wistar-Kyoto 和 Sprague Dawley 大鼠主动回避的数据集:实验数据和强化学习模型代码和输出。
- DOI:10.1016/j.dib.2020.106074
- 发表时间:2020
- 期刊:
- 影响因子:1.2
- 作者:Palmieri,John;Spiegler,KevinM;Pang,KevinCH;Myers,CatherineE
- 通讯作者:Myers,CatherineE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin C.H. Pang其他文献
Morphological and electrophysiological characteristics of noncholinergic basal forebrain neurons
非胆碱能基底前脑神经元的形态和电生理特征
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
Kevin C.H. Pang;Kevin C.H. Pang;J. Tepper;Laszlo Zaborszky - 通讯作者:
Laszlo Zaborszky
Kevin C.H. Pang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin C.H. Pang', 18)}}的其他基金
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk for suicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
- 批准号:
9888780 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Impaired attention & hippocampal dysfunction in developing abnormal avoidance
注意力受损
- 批准号:
8195591 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Hippocampus, synaptic plasticity and anxiety vulnerability
海马、突触可塑性和焦虑脆弱性
- 批准号:
8967080 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Impaired attention & hippocampal dysfunction in developing abnormal avoidance
注意力受损
- 批准号:
7789425 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Impaired attention & hippocampal dysfunction in developing abnormal avoidance
注意力受损
- 批准号:
8262608 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Impaired attention & hippocampal dysfunction in developing abnormal avoidance
注意力受损
- 批准号:
7684515 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Aging and the cholinergic system on attention and timing
衰老和胆碱能系统对注意力和计时的影响
- 批准号:
7348107 - 财政年份:2003
- 资助金额:
-- - 项目类别:
Aging and the cholinergic system on attention and timing
衰老和胆碱能系统对注意力和计时的影响
- 批准号:
7065221 - 财政年份:2003
- 资助金额:
-- - 项目类别:
Aging and the cholinergic system on attention and timing
衰老和胆碱能系统对注意力和计时的影响
- 批准号:
6701815 - 财政年份:2003
- 资助金额:
-- - 项目类别:
Aging and the cholinergic system on attention and timing
衰老和胆碱能系统对注意力和计时的影响
- 批准号:
6843739 - 财政年份:2003
- 资助金额:
-- - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
-- - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
-- - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)